Investors Offered Chance to Lead Lawsuit Against Park Ha Biological Technology
Rosen Law Firm is notifying investors of an opportunity to participate in a securities class action lawsuit concerning Park Ha Biological Technology Co., Ltd. The suit targets securities purchased between December 27, 2024, and July 8, 2025.
Rosen Law Firm, a global investor rights law firm, has alerted investors to a potential securities class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH). The action is open to purchasers of the company's securities who did so during the "Class Period," defined as December 27, 2024, through July 8, 2025.
Investors who acquired Park Ha Biological Technology securities within this timeframe are encouraged by the firm to contact them. The deadline to serve as a lead plaintiff in the action is September 2. The law firm has not yet detailed the specific claims or damages sought in the lawsuit.
Park Ha Biological Technology Co., Ltd. operates within the biotechnology sector. Its shares are traded on the NASDAQ stock exchange under the tickers PHH and BYAH. The notification from Rosen Law Firm, which represents investors, emphasizes the importance of timely action due to the upcoming deadline.
Further details regarding the lawsuit's basis and requirements for participation are available directly from Rosen Law Firm. The firm's announcement serves as an invitation for potential lead plaintiffs to come forward.